کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5621824 1579193 2017 7 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Full Length ArticleSafety of warfarin in “high-risk” populations: A meta-analysis of randomized and controlled trials
ترجمه فارسی عنوان
طول کامل داروها وارفارین در خطر بالا؟ جمعیت: یک متاآنالیز آزمایشات تصادفی و کنترل شده
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی کاردیولوژی و پزشکی قلب و عروق
چکیده انگلیسی


- We performed a meta-analysis to assess safety of Vitamin K antagonists in clinical settings with increased bleeding risk.
- Elderly age, low body weight and impaired renal function are associated with increased risk of bleeding in patients receiving VKAs.
- In “high-risk” patients under VKAs the increased bleeding risk is paralleled by an increased thrombotic risk.

IntroductionFew data are available about safety of vitamin K antagonists (VKAs) in patients with clinical/demographic characteristics predisposing to an increased risk of bleeding. We performed a meta-analysis to evaluate the safety of VKAs in patients with atrial fibrillation (AF) or venous thromboembolism (VTE) in the following subgroups of “high-risk” patients: elderly patients, patients with low body weight and patients with impaired renal function.Materials and methodsMajor electronic databases were systematically searched to identify randomized controlled trials (RCTs) addressing this issue. Pooled Risk Ratios (RR) and 95% Confidence Intervals (CI) were calculated for each outcome using a random effects model.ResultsEleven RCTs for a total of 41,015 patients treated with VKAs (25,901 with AF and 15,114 with VTE) were included. We found a significant association between age > 75 years and bleeding in patients receiving VKAs (RR: 1.62, 95%CI: 1.28-2.05; P < 0.0001). Moreover, the prevalence of bleeding events under VKAs was significantly higher in patients with low body weight (RR: 1.20, 95%CI: 1.03-1.40; P = 0.02) and in those with impaired renal function (RR: 1.59, 95%CI: 1.30-1.94; P < 0.00001). Results were confirmed when separately analyzing data on AF and VTE. Regression models showed that treatment duration did not impact on the differences found in the safety profile of VKAs in different settings analyzed.ConclusionsResults of our meta-analysis suggest an increased risk of bleeding complications in “high-risk” patients. Although all results are significant, other studies focused on this issue are warranted to further validate these results.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Thrombosis Research - Volume 150, February 2017, Pages 1-7
نویسندگان
, , ,